The Single-cell Analysis Market size was estimated USD 3.8 billion in 2022 and is expected to reach USD 14.4 billion by 2030 at a CAGR of 18.2% during the forecast period of 2023-2030.
Single-cell analysis, which involves the study of single-cell genomes, transcriptomes, proteomes, and metabolomes, and it is used in cancer research and the treatment of a wide range of chronic and infectious diseases. It is helpful for disclosing population, locating relevant market subpopulations, finding distinctive qualities of particular cells, and discovering heterogeneity.
.png)
The outbreak has led to a widespread adoption of SCA approaches in virology research. Researchers are using the samples from the COVID-19 biobanks for performing analysis to comprehend the profiles of infected patients in order to understand the immune response and the long-term impact of infections. For example, in 2022, scientists from The Human Cell Atlas Lung Biological Network and The NHLBI LungMap Consortium conducted a single-cell meta-analysis on 1,520,856 cells from 257 humans. The purpose of this work was to comprehend the SARS-CoV-2 entrance genes across demographics.
DRIVERS
Increasing prevalence of cancer
Finding cancer-related biomarkers requires a strong focus on single-cell analysis. According to GLOBOCAN By 2040, there will be almost 30 million new cases of cancer. Diverse cell populations within a tumor characterize cancer as a highly heterogeneous disease. Researchers can analyze individual cancer cells at the molecular level using single-cell analysis to break down this heterogeneity. Researchers are able to fully comprehend the variety of tumors by investigating gene expression, genetic alterations, and other biological traits at the single-cell level.
RESTRAIN
High cost of research of single cell biology
The high expense of single-cell biology research to maintain high standards (the use of expensive, high-grade materials) and follow the rules established by regulatory agencies is anticipated to restrain market expansion. Budget restrictions make it difficult for research and academic laboratories to afford such pricey tools. The overall cost is also increased as a result of the maintenance charges and various other indirect expenses.
OPPORTUNITY
High growth potential of single-cell sequencing
The remarkable resolution provided by single-cell sequencing enables researchers to visualize the cellular heterogeneity found in complex biological systems. Single-cell sequencing makes it possible to identify and analyze individual cells, in contrast to conventional bulk sequencing techniques that produce averaged findings. Researchers can now find uncommon cell Applications because to this better resolution. Discovering subpopulations and investigating dynamic cellular states will help to understand biological processes and disease mechanisms better.
CHALLENGES
Protocol standardization and data integration
Cell isolation, sample preparation, data analysis, and other procedures are all included in single-cell analysis. The lack of established methodologies across many platforms and facilities causes experimentation to vary and be inconsistent. Due to this, it is difficult to compare and integrate data from many studies, which hinders reproducibility and data sharing. Gene expression patterns, genetic variants, and phenotypic information at the individual cell level are just a few of the huge and intricate datasets produced by single-cell analysis. The different experimental setups, technologies, and analysis pipelines make it difficult to integrate and compare these datasets across investigations. To fully utilize single-cell analysis and enable meaningful cross-study comparisons, it is essential to harmonize data from various platforms and sources.
Ukrainian centers and research sites have gained invaluable experience in the logistics and ethics of continuing clinical research work in times of conflict. Dnipro State Medical University, for example, located relatively close to the front line that arcs up from Kherson in the south, through the Donbas, and ends further north, near Kharkiv, has treated approximately 200 patients in 28 clinical trials with over 3000 completed patient visits and 100% source data verification since the conflict began. The cancer center has learned vital lessons for doing clinical cancer research in high-risk contexts, which are applicable to many conflict-affected countries around the world, including the MENA region. 'The European Cancer Organisation American Society for Clinical Oncology (E.C.O - ASCO) Special Network on the Impact of the Ukrainian War on Cancer (E.C.O - ASCO) has promised its support in addressing this difficulty. As we evaluate how to best support clinical research in Ukraine and the integrity of research infrastructure in the region, the global oncology community must address these and other challenges urgently.
IMPACT OF ONGOING RECESSION
Urodynamic testing is the core of lower urinary tract dysfunction research. However, in the middle of the COVID-19 (coronavirus) pandemic, healthcare providers are adjusting to new urodynamics methods in order to maintain quality control in hospital settings. This has raised awareness among companies in the urodynamics equipment and disposables industry regarding the International Continence Society's (ICS) good urodynamics practice (GUD) guidelines. As a result, healthcare facilities are being closely monitored to prevent the spread of the unique virus due to a lack of hygiene, sanitization, and disinfection.
By Product
Instruments
Microscope
Hamocytometers
Flow Cytometers
NGS Systems
PCR
High Content Screening Systems
Cell Microarrays
Single Live Cell Imaging
Automated Cell Counters
Consumables
Reagents
Assay Kits
In 2022, Consumables segment is expected to held the highest market share of 54.2% in during the forecast period due to high usage of isolation products, cell sorting beads are widely used, buffers and reWorkflows are frequently purchased, and there is an increasing need for assay kits. The rise in the incidence of the target disorders and the ongoing need for the supplies needed for the tests during research activities are propelling the segment's expansion.
By Workflow
Single Cell Isolation & Library Preparation
Downstream Analysis
Data Analysis
In 2022, Single Cell Isolation & Library Preparation segment is expected to dominate the market share of 37.5% during the forecast period due to the need for kits and reWorkflows for cell isolation and library preparation has risen as a result of the wide range of SCA applications. Additionally, a sizable number of market participants are providing a variety of single-cell isolation products, including, to name a few, FACS and MACS for heterogeneous cell suspensions, microdissection of fixed tissue samples, flow cytometry, and microfluidics. This is helping this market segment grow in terms of revenue.
By Application
Cancer
Immunology
Neurology
Stem Cell
Non-Invasive Prenatal Diagnosis
In-Vitro Fertilization
Others
In 2022, the Cancer segment is expected to dominate the market share of 33.2% and also expected to be the fastest growing segment of the market with a CAGR of 19.87% during the forecast period. For accurately identifying cancer cells, single-cell analysis has shown to be useful. These techniques enable the rapid identification of genetic variation via cell growth settings, mutation rates, and cell applications. The American Cancer Society reports that, behind heart disease, cancer is the second most prevalent cause of death in the country. An estimated 1.93 million new instances of cancer are anticipated in the United States in 2022, according to cancer statistics. Therefore, it is expected that the rising incidence of cancer and the ongoing research and development in this area would have a beneficial effect on the expansion of the market.
By End User
Academic & Research Laboratories
Biotechnology & Pharmaceutical Companies
Hospitals & Diagnostic Laboratories
Others
.png)
In 2022, the academic & research laboratories segment is expected to dominate the market growth of 73.7% during the forecast period because single-cell analysis technology is widely used in research settings. due to the widespread usage of single-cell analysis techniques in academic contexts. Its acceptance in 2022 has been prompted by the sizable number of active scientific research using SCA techniques at numerous colleges. Another important aspect influencing the market is the development of spatial genomics, which speeds up single-cell analysis in research activities. Additionally, creating new tools to address research limitations is propelling the industry. For example, in june 2022, researchers at Stony Brook University in New York created the single-cell cyclic multiplex in situ tagging (CycMIST) technology, a new biomedical research tool. Scientists can evaluate functioning proteins in a single cell using this method, which advances the fields of diagnosis and discovery.
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
REGIONAL ANALYSES
North America held a significant market share growing with a CAGR of 35.8% in 2022. This can be attributed to a number of government funding initiatives, increased public knowledge of personal healthcare needs and costs, quicker adoption of novel analytical tools and procedures, and the availability of qualified employees, among other things. The rise of the industry in North America is mostly due to the U.S. For example, metabolomics research is supported by the American NIH (National Institutes of Health) through its Common Fund Programs. Previously, the NIH had used the same funds to support the single cell analysis program (SCAP). The existence of important market participants, the demand for tailored medications, and the region's exceptional healthcare infrastructure are some of the main drivers of regional growth.
Asia-Pacific is witness to expand fastest CAGR rate of 19.9% during the forecast period. The demand for cutting-edge diagnostic equipment in the developing countries of Asia Pacific has been fueled by the expanding medical industry, fast evolving healthcare systems, and rising elderly population. The region has experienced substantial growth as a result of concerted efforts and outsourcing.
The major key players are Thermo Fisher Scientific, Inc., QIAGEN NV, Bio-Rad Laboratories Inc., Illumina Inc., Merck KGaA, Becton, Dickinson & Company, Fluidigm Corporation, 10x Genomics, Inc., BGI, Novogene Corporation, and Others.
Becton, Dikinson and Company, in May 2023, The BD FACSDiscover $8 Cell Sorter, a brand-new cell sorting device with two ground-breaking technologies, was introduced by Becton, Dikinson and Company. It enables researchers to find out more specific information about cells that was previously hidden in conventional flow cytometry experiments.
Merck KGaA, in June 2022, to enhance Process Analytical Technologies (PAT), Merck KGaA worked with Agilent Technologies. PAT is a crucial enabler for real-time release and Bioprocessing 4.0 and is widely advocated by international regulatory bodies.
| Report Attributes | Details |
| Market Size in 2022 | US$ 3.8 Billion |
| Market Size by 2030 | US$ 14.4 Billion |
| CAGR | CAGR of 18.2% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2019-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Instruments, Consumables) • By Workflow (Single Cell Isolation & Library Preparation, Downstream Analysis, Data Analysis) • By Application (Cancer, Immunology, Neurology, Stem Cell, Non-Invasive Prenatal Diagnosis, In-Vitro Fertilization, Others) • By End User (Academic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Thermo Fisher Scientific, Inc., QIAGEN NV, Bio-Rad Laboratories Inc., Illumina Inc., Merck KGaA, Becton, Dickinson & Company, Fluidigm Corporation, 10x Genomics, Inc., BGI, Novogene Corporation |
| Key Drivers | • Increasing prevalence of cancer |
| Market Challenges | • Protocol standardization and data integration |
Ans: The Single-cell Analysis Market is expected to grow at 18.2% CAGR from 2023 to 2030.
Ans: According to our analysis, the Single-cell Analysis Market is anticipated to reach USD 14.4 billion By 2030.
Ans: Single-cell Analysis Market size was valued at USD 3.8 billion in 2022.
Ans: Challenge such as Protocol standardization and data integration.
Ans: Yes, you may request customization based on your company's needs.
TABLE OF CONTENT
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Single-cell Analysis Market Segmentation, by Product
8.1 Instruments
8.1.1 Microscope
8.1.2 Hamocytometers
8.1.3 Flow Cytometers
8.1.4 NGS Systems
8.1.5 PCR
8.1.6 High Content Screening Systems
8.1.7 Cell Microarrays
8.1.8 Single Live Cell Imaging
8.1.9 Automated Cell Counters
8.2 Consumables
8.2.1 Reagents
8.2.2 Assay Kits
9. Single-cell Analysis Market Segmentation, by Workflow
9.1 Single Cell Isolation & Library Preparation
9.2 Downstream Analysis
9.3 Data Analysis
10. Single-cell Analysis Market Segmentation, by Application
10.1 Cancer
10.2 Immunology
10.3 Neurology
10.4 Stem Cell
10.5 In-Vitro Fertilization
10.6 Others
11. Single-cell Analysis Market Segmentation, by End User
11.1 Academic & Research Laboratories
11.2 Biotechnology & Pharmaceutical Companies
11.3 Hospitals & Diagnostic Laboratories
11.4 Others
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 North America Single-cell Analysis Market by Country
12.2.2North America Single-cell Analysis Market by Product
12.2.3 North America Single-cell Analysis Market by Workflow
12.2.4 North America Single-cell Analysis Market by Application
12.2.5 North America Single-cell Analysis Market by End User
12.2.6 USA
12.2.6.1 USA Single-cell Analysis Market by Product
12.2.6.2 USA Single-cell Analysis Market by Workflow
12.2.6.3 USA Single-cell Analysis Market by Application
12.2.6.4 USA Single-cell Analysis Market by End User
12.2.7 Canada
12.2.7.1 Canada Single-cell Analysis Market by Product
12.2.7.2 Canada Single-cell Analysis Market by Workflow
12.2.7.3 Canada Single-cell Analysis Market by Application
12.2.7.4 Canada Single-cell Analysis Market by End User
12.2.8 Mexico
12.2.8.1 Mexico Single-cell Analysis Market by Product
12.2.8.2 Mexico Single-cell Analysis Market by Workflow
12.2.8.3 Mexico Single-cell Analysis Market by Application
12.2.8.4 Mexico Single-cell Analysis Market by End User
12.3 Europe
12.3.1 Eastern Europe
12.3.1.1 Eastern Europe Single-cell Analysis Market by Country
12.3.1.2 Eastern Europe Single-cell Analysis Market by Product
12.3.1.3 Eastern Europe Single-cell Analysis Market by Workflow
12.3.1.4 Eastern Europe Single-cell Analysis Market by Application
12.3.1.5 Eastern Europe Single-cell Analysis Market by End User
12.3.1.6 Poland
12.3.1.6.1 Poland Single-cell Analysis Market by Product
12.3.1.6.2 Poland Single-cell Analysis Market by Workflow
12.3.1.6.3 Poland Single-cell Analysis Market by Application
12.3.1.6.4 Poland Single-cell Analysis Market by End User
12.3.1.7 Romania
12.3.1.7.1 Romania Single-cell Analysis Market by Product
12.3.1.7.2 Romania Single-cell Analysis Market by Workflow
12.3.1.7.3 Romania Single-cell Analysis Market by Application
12.3.1.7.4 Romania Single-cell Analysis Market by End User
12.3.1.8 Hungary
12.3.1.8.1 Hungary Single-cell Analysis Market by Product
12.3.1.8.2 Hungary Single-cell Analysis Market by Workflow
12.3.1.8.3 Hungary Single-cell Analysis Market by Application
12.3.1.8.4 Hungary Single-cell Analysis Market by End User
12.3.1.9 Turkey
12.3.1.9.1 Turkey Single-cell Analysis Market by Product
12.3.1.9.2 Turkey Single-cell Analysis Market by Workflow
12.3.1.9.3 Turkey Single-cell Analysis Market by Application
12.3.1.9.4 Turkey Single-cell Analysis Market by End User
12.3.1.10 Rest of Eastern Europe
12.3.1.10.1 Rest of Eastern Europe Single-cell Analysis Market by Product
12.3.1.10.2 Rest of Eastern Europe Single-cell Analysis Market by Workflow
12.3.1.10.3 Rest of Eastern Europe Single-cell Analysis Market by Application
12.3.1.10.4 Rest of Eastern Europe Single-cell Analysis Market by End User
12.3.2 Western Europe
12.3.2.1 Western Europe Single-cell Analysis Market by Country
12.3.2.2 Western Europe Single-cell Analysis Market by Product
12.3.2.3 Western Europe Single-cell Analysis Market by Workflow
12.3.2.4 Western Europe Single-cell Analysis Market by Application
12.3.2.5 Western Europe Single-cell Analysis Market by End User
12.3.2.6 Germany
12.3.2.6.1 Germany Single-cell Analysis Market by Product
12.3.2.6.2 Germany Single-cell Analysis Market by Workflow
12.3.2.6.3 Germany Single-cell Analysis Market by Application
12.3.2.6.4 Germany Single-cell Analysis Market by End User
12.3.2.7 France
12.3.2.7.1 France Single-cell Analysis Market by Product
12.3.2.7.2 France Single-cell Analysis Market by Workflow
12.3.2.7.3 France Single-cell Analysis Market by Application
12.3.2.7.4 France Single-cell Analysis Market by End User
12.3.2.8 UK
12.3.2.8.1 UK Single-cell Analysis Market by Product
12.3.2.8.2 UK Single-cell Analysis Market by Workflow
12.3.2.8.3 UK Single-cell Analysis Market by Application
12.3.2.8.4 UK Single-cell Analysis Market by End User
12.3.2.9 Italy
12.3.2.9.1 Italy Single-cell Analysis Market by Product
12.3.2.9.2 Italy Single-cell Analysis Market by Workflow
12.3.2.9.3 Italy Single-cell Analysis Market by Application
12.3.2.9.4 Italy Single-cell Analysis Market by End User
12.3.2.10 Spain
12.3.2.10.1 Spain Single-cell Analysis Market by Product
12.3.2.10.2 Spain Single-cell Analysis Market by Workflow
12.3.2.10.3 Spain Single-cell Analysis Market by Application
12.3.2.10.4 Spain Single-cell Analysis Market by End User
12.3.2.11 Netherlands
12.3.2.11.1 Netherlands Single-cell Analysis Market by Product
12.3.2.11.2 Netherlands Single-cell Analysis Market by Workflow
12.3.2.11.3 Netherlands Single-cell Analysis Market by Application
12.3.2.11.4 Netherlands Single-cell Analysis Market by End User
12.3.2.12 Switzerland
12.3.2.12.1 Switzerland Single-cell Analysis Market by Product
12.3.2.12.2 Switzerland Single-cell Analysis Market by Workflow
12.3.2.12.3 Switzerland Single-cell Analysis Market by Application
12.3.2.12.4 Switzerland Single-cell Analysis Market by End User
12.3.2.13 Austria
12.3.2.13.1 Austria Single-cell Analysis Market by Product
12.3.2.13.2 Austria Single-cell Analysis Market by Workflow
12.3.2.13.3 Austria Single-cell Analysis Market by Application
12.3.2.13.4 Austria Single-cell Analysis Market by End User
12.3.2.14 Rest of Western Europe
12.3.2.14.1 Rest of Western Europe Single-cell Analysis Market by Product
12.3.2.14.2 Rest of Western Europe Single-cell Analysis Market by Workflow
12.3.2.14.3 Rest of Western Europe Single-cell Analysis Market by Application
12.3.2.14.4 Rest of Western Europe Single-cell Analysis Market by End User
12.4 Asia-Pacific
12.4.1 Asia Pacific Single-cell Analysis Market by Country
12.4.2 Asia Pacific Single-cell Analysis Market by Product
12.4.3 Asia Pacific Single-cell Analysis Market by Workflow
12.4.4 Asia Pacific Single-cell Analysis Market by Application
12.4.5 Asia Pacific Single-cell Analysis Market by End User
12.4.6 China
12.4.6.1 China Single-cell Analysis Market by Product
12.4.6.2 China Single-cell Analysis Market by Workflow
12.4.6.3 China Single-cell Analysis Market by Application
12.4.6.4 China Single-cell Analysis Market by End User
12.4.7 India
12.4.7.1 India Single-cell Analysis Market by Product
12.4.7.2 India Single-cell Analysis Market by Workflow
12.4.7.3 India Single-cell Analysis Market by Application
12.4.7.4 India Single-cell Analysis Market by End User
12.4.8 Japan
12.4.8.1 Japan Single-cell Analysis Market by Product
12.4.8.2 Japan Single-cell Analysis Market by Workflow
12.4.8.3 Japan Single-cell Analysis Market by Application
12.4.8.4 Japan Single-cell Analysis Market by End User
12.4.9 South Korea
12.4.9.1 South Korea Single-cell Analysis Market by Product
12.4.9.2 South Korea Single-cell Analysis Market by Workflow
12.4.9.3 South Korea Single-cell Analysis Market by Application
12.4.9.4 South Korea Single-cell Analysis Market by End User
12.4.10 Vietnam
12.4.10.1 Vietnam Single-cell Analysis Market by Product
12.4.10.2 Vietnam Single-cell Analysis Market by Workflow
12.4.10.3 Vietnam Single-cell Analysis Market by Application
12.4.10.4 Vietnam Single-cell Analysis Market by End User
12.4.11 Singapore
12.4.11.1 Singapore Single-cell Analysis Market by Product
12.4.11.2 Singapore Single-cell Analysis Market by Workflow
12.4.11.3 Singapore Single-cell Analysis Market by Application
12.4.11.4 Singapore Single-cell Analysis Market by End User
12.4.12 Australia
12.4.12.1 Australia Single-cell Analysis Market by Product
12.4.12.2 Australia Single-cell Analysis Market by Workflow
12.4.12.3 Australia Single-cell Analysis Market by Application
12.4.12.4 Australia Single-cell Analysis Market by End User
12.4.13 Rest of Asia-Pacific
12.4.13.1 Rest of Asia-Pacific Single-cell Analysis Market by Product
12.4.13.2 Rest of Asia-Pacific Single-cell Analysis Market by Workflow
12.4.13.3 Rest of Asia-Pacific Single-cell Analysis Market by Application
12.4.13.4 Rest of Asia-Pacific Single-cell Analysis Market by End User
12.5 Middle East & Africa
12.5.1 Middle East
12.5.1.1 Middle East Single-cell Analysis Market by country
12.5.1.2 Middle East Single-cell Analysis Market by Product
12.5.1.3 Middle East Single-cell Analysis Market by Workflow
12.5.1.4 Middle East Single-cell Analysis Market by Application
12.5.1.5 Middle East Single-cell Analysis Market by End User
12.5.1.6 UAE
12.5.1.6.1 UAE Single-cell Analysis Market by Product
12.5.1.6.2 UAE Single-cell Analysis Market by Workflow
12.5.1.6.3 UAE Single-cell Analysis Market by Application
12.5.1.6.4 UAE Single-cell Analysis Market by End User
12.5.1.7 Egypt
12.5.1.7.1 Egypt Single-cell Analysis Market by Product
12.5.1.7.2 Egypt Single-cell Analysis Market by Workflow
12.5.1.7.3 Egypt Single-cell Analysis Market by Application
12.5.1.7.4 Egypt Single-cell Analysis Market by End User
12.5.1.8 Saudi Arabia
12.5.1.8.1 Saudi Arabia Single-cell Analysis Market by Product
12.5.1.8.2 Saudi Arabia Single-cell Analysis Market by Workflow
12.5.1.8.3 Saudi Arabia Single-cell Analysis Market by Application
12.5.1.8.4 Saudi Arabia Single-cell Analysis Market by End User
12.5.1.9 Qatar
12.5.1.9.1 Qatar Single-cell Analysis Market by Product
12.5.1.9.2 Qatar Single-cell Analysis Market by Workflow
12.5.1.9.3 Qatar Single-cell Analysis Market by Application
12.5.1.9.4 Qatar Single-cell Analysis Market by End User
12.5.1.10 Rest of Middle East
12.5.1.10.1 Rest of Middle East Single-cell Analysis Market by Product
12.5.1.10.2 Rest of Middle East Single-cell Analysis Market by Workflow
12.5.1.10.3 Rest of Middle East Single-cell Analysis Market by Application
12.5.1.10.4 Rest of Middle East Single-cell Analysis Market by End User
12.5.2. Africa
12.5.2.1 Africa Single-cell Analysis Market by country
12.5.2.2 Africa Single-cell Analysis Market by Product
12.5.2.3 Africa Single-cell Analysis Market by Workflow
12.5.2.4 Africa Single-cell Analysis Market by Application
12.5.2.5 Africa Single-cell Analysis Market by End User
12.5.2.6 Nigeria
12.5.2.6.1 Nigeria Single-cell Analysis Market by Product
12.5.2.6.2 Nigeria Single-cell Analysis Market by Workflow
12.5.2.6.3 Nigeria Single-cell Analysis Market by Application
12.5.2.6.4 Nigeria Single-cell Analysis Market by End User
12.5.2.7 South Africa
12.5.2.7.1 South Africa Single-cell Analysis Market by Product
12.5.2.7.2 South Africa Single-cell Analysis Market by Workflow
12.5.2.7.3 South Africa Single-cell Analysis Market by Application
12.5.2.7.4 South Africa Single-cell Analysis Market by End User
12.5.2.8 Rest of Africa
12.5.2.8.1 Rest of Africa Single-cell Analysis Market by Product
12.5.2.8.2 Rest of Africa Single-cell Analysis Market by Workflow
12.5.2.8.3 Rest of Africa Single-cell Analysis Market by Application
12.5.2.8.4 Rest of Africa Single-cell Analysis Market by End User
12.6. Latin America
12.6.1 Latin America Single-cell Analysis Market by country
12.6.2 Latin America Single-cell Analysis Market by Product
12.6.3 Latin America Single-cell Analysis Market by Workflow
12.6.4 Latin America Single-cell Analysis Market by Application
12.6.5 Latin America Single-cell Analysis Market by End User
12.6.6 Brazil
12.6.6.1 Brazil Single-cell Analysis Market by Product
12.6.6.2 Brazil Single-cell Analysis Market by Workflow
12.6.6.3 Brazil Single-cell Analysis Market by Application
12.6.6.4 Brazil Single-cell Analysis Market by End User
12.6.7 Argentina
12.6.7.1 Argentina Single-cell Analysis Market by Product
12.6.7.2 Argentina Single-cell Analysis Market by Workflow
12.6.7.3 Argentina Single-cell Analysis Market by Application
12.6.7.4 Argentina Single-cell Analysis Market by End User
12.6.8 Colombia
12.6.8.1 Colombia Single-cell Analysis Market by Product
12.6.8.2 Colombia Single-cell Analysis Market by Workflow
12.6.8.3 Colombia Single-cell Analysis Market by Application
12.6.8.4 Colombia Single-cell Analysis Market by End User
12.6.9 Rest of Latin America
12.6.9.1 Rest of Latin America Single-cell Analysis Market by Product
12.6.9.2 Rest of Latin America Single-cell Analysis Market by Workflow
12.6.9.3 Rest of Latin America Single-cell Analysis Market by Application
12.6.9.4 Rest of Latin America Single-cell Analysis Market by End User
13 Company Profile
13.1 Thermo Fisher Scientific, Inc.
13.1.1 Company Overview
13.1.2 Financials
13.1.3 Products/ Services Offered
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 QIAGEN NV
13.2.1 Company Overview
13.2.2 Financials
13.2.3 Products/ Services Offered
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 Bio-Rad Laboratories Inc.
13.3.1 Company Overview
13.3.2 Financials
13.3.3 Products/ Services Offered
13.3.4 SWOT Analysis
13.3.5 The SNS View
13.4 Illumina Inc.
13.4 Company Overview
13.4.2 Financials
13.4.3 Products/ Services Offered
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 Merck KGaA
13.5.1 Company Overview
13.5.2 Financials
13.5.3 Products/ Services Offered
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 Becton, Dickinson & Company
13.6.1 Company Overview
13.6.2 Financials
13.6.3 Products/ Services Offered
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 Fluidigm Corporation
13.7.1 Company Overview
13.7.2 Financials
13.7.3 Products/ Services Offered
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8 10x Genomics, Inc.
13.8.1 Company Overview
13.8.2 Financials
13.8.3 Products/ Services Offered
13.8.4 SWOT Analysis
13.8.5 The SNS View
13.9 BGI
13.9.1 Company Overview
13.9.2 Financials
13.9.3 Products/ Services Offered
13.9.4 SWOT Analysis
13.9.5 The SNS View
13.10 Novogene Corporation
13.10.1 Company Overview
13.10.2 Financials
13.10.3 Products/ Services Offered
13.10.4 SWOT Analysis
13.10.5 The SNS View
13.11 Others
14. Competitive Landscape
14.1 Competitive Bench marking
14.2 Market Share Analysis
14.3 Recent Developments
14.3.1 Industry News
14.3.2 Company News
14.3.3 Mergers & Acquisitions
15. USE Cases and Best Practices
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Healthcare Virtual Assistants Market size was valued at USD 957.61 million in 2022 and is projected to reach USD 10.44 billion with a growing CAGR of 34.8% over the forecast period 2023-2030.
The Cardiology Information System (CIS) Market Size was valued at USD 1051.77 million in 2022, and is expected to reach USD 2158.03 million by 2030, and grow at a CAGR of 9.4% over the forecast period 2023-2030.
The Biosimulation Market Size was valued at USD 2.4 billion in 2023 and is expected to reach USD 8.4 billion by 2031, and grow at a CAGR of 17.0% over the forecast period 2024-2031.
The Medical Device Security Market Size was valued at USD 6.09 billion in 2022 and is expected to reach USD 12.06 billion by 2030 and grow at a CAGR of 8.9% over the forecast period 2023-2030.
The Respiratory Care Device Market was esteemed at USD 19.49 billion in 2022, and is to reach USD 38.55 billion by 2030, enrolling an expected CAGR of 8.9% during the forecast period 2023-2030.
The Healthcare Biometrics Market Size was valued at USD 537.03 million in 2022 and is expected to reach USD 2263.3 million by 2030 and grow at a CAGR of 19.7% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
